Healthy high growth potential

Results

1542

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1542 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
SAUD3
R$13.77-3.0%7.6%R$40.3bR$17.6938.231.9%5.9%Healthcare
002975
CN¥99.992.1%159.7%CN¥20.8bCN¥130.0089.444.2%0%Tech
688072
CN¥688.20-0.4%314.1%CN¥199.2bCN¥681.93121.146.8%0.05%Semiconductors
1860
HK$11.393.1%-11.0%HK$17.5bHK$18.2629.941.1%n/aMedia
600183
CN¥143.212.3%219.5%CN¥347.9bCN¥155.0867.028.5%1.1%Tech
2480
HK$13.10-3.7%-44.3%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
2171
HK$15.01-2.1%-33.9%HK$8.9bHK$21.1961.080.6%n/aPharmaceuticals & Biotech
541967
₹773.057.8%182.6%₹119.7b₹915.3335.727.7%0%Consumer Durables
7769
NT$6,590.004.3%314.5%NT$1.2tNT$9,210.1868.047.9%1.0%Semiconductors
3881
HK$19.82-5.3%n/aHK$8.7bn/a5.8119.5%n/aCapital Goods
3636
HK$16.97-1.9%n/aHK$2.6bHK$31.236.840.2%2.3%Materials
002709
CN¥39.470.4%95.4%CN¥80.1bCN¥65.0827.928.3%0.6%Materials
4417
JP¥4,760.00-4.1%50.6%JP¥71.4bJP¥5,800.0044.426.4%1.0%Software
6990
HK$520.50-3.5%19.9%HK$124.4bHK$570.0551.945.1%n/aPharmaceuticals & Biotech
1729
HK$16.547.8%38.5%HK$36.9bHK$28.7547.137.1%0.3%Capital Goods
MONOLITH
₹950.252.4%137.6%₹20.7b₹1,060.0072.035.6%n/aMaterials
688192
CN¥60.918.8%-28.5%CN¥28.3bCN¥83.0031.7104.5%n/aPharmaceuticals & Biotech
688700
CN¥57.82-7.9%23.0%CN¥17.2bCN¥61.6797.061.7%0.3%Capital Goods
3036
NT$210.00-0.7%67.3%NT$266.8bNT$314.8610.928.9%3.7%Tech
1357
HK$4.50-5.4%-57.9%HK$20.4bHK$8.7824.031.3%2.2%Media
3277
HK$73.30-1.2%n/aHK$32.6bHK$115.3595.334.2%0.4%Tech
SAATVIKGL
₹427.400.9%n/a₹54.3b₹542.5022.164.0%n/aSemiconductors
456A
JP¥1,429.003.2%n/aJP¥131.0bn/a40.423.4%n/aRetail
688270
CN¥66.65-3.5%38.3%CN¥19.9bCN¥185.71132.885.5%0%Semiconductors
Page 1 of 43
Healthy high growth potential - Investing Ideas - Simply Wall St